Quantitative study of insulin secretion and clearance in normal and obese subjects - PubMed (original) (raw)
Quantitative study of insulin secretion and clearance in normal and obese subjects
K S Polonsky et al. J Clin Invest. 1988 Feb.
Abstract
The secretion and hepatic extraction of insulin were compared in 14 normal volunteers and 15 obese subjects using a previously validated mathematical model of insulin secretion and rate constants for C-peptide derived from analysis of individual decay curves after intravenous bolus injections of biosynthetic human C-peptide. Insulin secretion rates were substantially higher than normal in the obese subjects after an overnight fast (86.7 +/- 7.1 vs. 50.9 +/- 4.8 pmol/m2 per min, P less than 0.001, mean +/- SEM), over a 24-h period on a mixed diet (279.6 +/- 24.2 vs. 145.8 +/- 8.8 nmol/m2 per 24 h, P less than 0.001), and during a hyperglycemic intravenous glucose infusion (102.2 +/- 10.8 vs. 57.2 +/- 2.8 nmol/m2 per 180 min, P less than 0.001). Linear regression analysis revealed a highly significant relationship between insulin secretion and body mass index. Basal hepatic insulin extraction was not significantly different in the normal and obese subjects (53.1 +/- 3.8 vs. 51.6 +/- 4.0%). In the normal subjects, fasting insulin did not correlate with basal hepatic insulin extraction, but a significant negative correlation between fasting insulin and hepatic insulin extraction was seen in obesity (r = -0.63, P less than 0.02). This finding reflected a higher extraction in the six obese subjects with fasting insulin levels within the range of the normal subjects than in the nine subjects with elevated fasting insulin concentrations (61 +/- 3 vs. 45 +/- 6%, P less than 0.05). During the hyperglycemic clamp, the insulin secretion rate increased to an average maximum of 6.2-fold over baseline in the normal subjects and 5.8-fold in the obese subjects. Over the same time, the peripheral insulin concentration increased 14.1-fold over baseline in the normals and 16.6-fold over baseline in the obese, indicating a reduction in the clearance of endogenously secreted insulin. Although the fall in insulin clearance tended to be greater in the obese subjects, the differences between the two groups were not statistically significant. Thus, under basal, fasting conditions and during ingestion of a mixed diet, the hyperinsulinemia of obesity results predominantly from increased insulin secretion. In patients with more marked basal hyperinsulinemia and during intense stimulation of insulin secretion, a reduction in insulin clearance may contribute to the greater increase in peripheral insulin concentrations that are characteristic of the obese state.+
Similar articles
- Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel G, Henry RR. Gumbiner B, et al. J Clin Endocrinol Metab. 1990 Jun;70(6):1594-602. doi: 10.1210/jcem-70-6-1594. J Clin Endocrinol Metab. 1990. PMID: 2189885 - Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.
Polonsky KS, Given BD, Van Cauter E. Polonsky KS, et al. J Clin Invest. 1988 Feb;81(2):442-8. doi: 10.1172/JCI113339. J Clin Invest. 1988. PMID: 3276730 Free PMC article. - Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans.
Meier JJ, Veldhuis JD, Butler PC. Meier JJ, et al. Diabetes. 2005 Jun;54(6):1649-56. doi: 10.2337/diabetes.54.6.1649. Diabetes. 2005. PMID: 15919785 - C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations.
Polonsky KS, Rubenstein AH. Polonsky KS, et al. Diabetes. 1984 May;33(5):486-94. doi: 10.2337/diab.33.5.486. Diabetes. 1984. PMID: 6373457 Review. - Current approaches to measurement of insulin secretion.
Polonsky KS, Rubenstein AH. Polonsky KS, et al. Diabetes Metab Rev. 1986;2(3-4):315-29. doi: 10.1002/dmr.5610020306. Diabetes Metab Rev. 1986. PMID: 3527618 Review.
Cited by
- High Doses of Exogenous Glucagon Stimulate Insulin Secretion and Reduce Insulin Clearance in Healthy Humans.
Gray SM, Goonatilleke E, Emrick MA, Becker JO, Hoofnagle AN, Stefanovski D, He W, Zhang G, Tong J, Campbell J, D'Alessio DA. Gray SM, et al. Diabetes. 2024 Mar 1;73(3):412-425. doi: 10.2337/db23-0201. Diabetes. 2024. PMID: 38015721 - Insulin Clearance at the Pubertal Transition in Youth with Obesity and Steatosis Liver Disease.
Franceschi R, Fintini D, Ravà L, Mariani M, Aureli A, Inzaghi E, Pedicelli S, Deodati A, Bizzarri C, Cappa M, Cianfarani S, Manco M. Franceschi R, et al. Int J Mol Sci. 2023 Oct 6;24(19):14963. doi: 10.3390/ijms241914963. Int J Mol Sci. 2023. PMID: 37834412 Free PMC article. - Can Circadian Eating Pattern Adjustments Reduce Risk or Prevent Development of T2D?
Harris C, Czaja K. Harris C, et al. Nutrients. 2023 Apr 4;15(7):1762. doi: 10.3390/nu15071762. Nutrients. 2023. PMID: 37049602 Free PMC article. Review. - β-Cell Function and Insulin Sensitivity in Youth With Early Type 1 Diabetes From a 2-Hour 7-Sample OGTT.
Galderisi A, Evans-Molina C, Martino M, Caprio S, Cobelli C, Moran A. Galderisi A, et al. J Clin Endocrinol Metab. 2023 May 17;108(6):1376-1386. doi: 10.1210/clinem/dgac740. J Clin Endocrinol Metab. 2023. PMID: 36546354 Free PMC article. - Various Aspects of Fasting on the Biodistribution of Radiopharmaceuticals.
Ahmadpour S, Habibi MA, Hosseinimehr SJ. Ahmadpour S, et al. Curr Drug Metab. 2022;23(10):827-841. doi: 10.2174/1389200223666220919121354. Curr Drug Metab. 2022. PMID: 36121082 Review.
References
- J Clin Invest. 1973 Aug;52(8):2016-28 - PubMed
- Metabolism. 1987 Mar;36(3):219-22 - PubMed
- Diabetes. 1978;27 Suppl 1:170-7 - PubMed
- J Clin Endocrinol Metab. 1979 Apr;48(4):594-8 - PubMed
- Diabetologia. 1979 Oct;17(4):221-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical